S387 Dupilumab Improves Clinical, Symptomatic, Histologic, and Endoscopic Aspects of EoE up to 24 Weeks: Pooled Results From Parts A and B of Phase 3 LIBERTY-EoE-TREET. (October 2022) - Rothenberg, Marc; Bredenoord, Albert; Lucendo, Alfredo; Hirano, Ikuo; Sun, Xian; Patel, Kiran; Beazley, Bethany